This Drug Stock Has Crushed the S&P 500 Over the Last Decade

Eli Lilly is leading the GLP-1 charge, but investors have already priced much of the good news into the stock.

MIKE: Lily P. Crumbs aka Alex George joins MIKE. Plus...MIKE vs Gen Z. - Episode 106

On this episode of MIKE, Lily P. Crumbs also known as Alex George joins MIKE to talk about her new book, overcoming cancer, ...
Benzinga.com

P/E Ratio Insights for Eli Lilly

The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and ...
MarketWatch

Lilly's stock leads S&P 500 losers as Mounjaro, Zepbound sales to miss forecasts

Shares of Eli Lilly were taking a 6.9% hit toward a two-month low in recent trading, enough to make them the S&P 500's biggest decliner. The problem is that the drug giant provided fourth-quarter ...
Nasdaq

Lilly to participate in J.P. Morgan Healthcare Conference

INDIANAPOLIS, Dec. 16, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the 44th Annual J.P. Morgan Healthcare Conference, Jan. 12-15, 2025. David A. Ricks, Lilly chair and ...